Funding Details
- Awarder
- Inbox
- Date Award
- January 09, 2025
- Vertical
- Biotech
- Funding URL
- View Funding Page
Company Info
- Founding Year
- 2025
- Traction
- Verdiva Bio has secured $411 million in Series A financing, making it one of the largest funding rounds in the biotech sector since 2022.
- Founders
- Khurem Farooq, Jane Hughes, Tapan Maniar, Ashley Taylor, Mark Pruzanski
- Company Description
- Verdiva Bio is a newly launched biotech company focused on developing obesity treatments. It has licensed a portfolio of weight loss medicines from Sciwind Biosciences in China, including an oral therapy ready for Phase 2 testing.
- Market
- Obesity treatments
- Location
-
China
- Coinvestors
- Forbion, General Atlantic, RA Capital Management, OrbiMed, Logos Capital, Lilly Asia Ventures, LYFE Capital
Links